Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
KLK2-comPAS trial: what clinicians have said so far
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT07164443 ↗
- Recruiting
- Janssen Research & Development, LLC
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on KLK2-comPAS (pasritamig; pasritamig plus JNJ-87189401 in late-line metastatic castration-resistant prostate cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on KLK2-comPAS so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 4 posts on X |
The trial
ClinicalTrials.gov- Official title
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study of Pasritamig (JNJ-78278343), a T Cell Engaging Agent Targeting Human Kallikrein 2, With or Without JNJ-87189401, a PSMA-CD28 Costimulatory Agent, Plus Best Supportive Care Versus Best Supportive Care for Late-line Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Metastatic Castration-resistant Prostatic Neoplasms
- Interventions
- Pasritamig; Placebo; Best Supportive Care (BSC); JNJ-87189401
- Arms
- Part 1: Pasritamig+Best Supportive Care (BSC) · Experimental
- Part 1: Placebo+BSC · Placebo comparator
- Part 2: Pasritamig+BSC · Experimental
- Part 2: Pasritamig+JNJ-87189401+BSC · Experimental
- Part 2: Placebo +BSC · Placebo comparator
- Enrollment
- 1,203 (estimated)
- Primary outcomes
- Overall Survival (OS)
- Sponsor
- Janssen Research & Development, LLC
- Start
- Sep 2, 2025
- Primary completion
- Aug 18, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT07164443 · updated Nov 3, 2026